Loading quotes...
Forecast
The analysts' average price target is €88.01 (+18.69%). The median is €85.20 (+14.90%).
| Buy |
25 |
| Hold |
8 |
| Sell |
1 |
News Go to news feed
International Flavors & Fragrances posts volume-driven Q2 growth, advances Food Ingredients sale
International Flavors & Fragrances reported continuing-operations Q2 sales up about 6% to nearly $2 billion and adjusted operating EBITDA up 6% to $408 million, driven by volume gains across Taste, Health & Biosciences and Scent. The company agreed to sell Food Ingredients to CVC Capital Partners for about $4.3 billion while retaining a 10% stake, plans to use over $1 billion of proceeds to cut debt and will address roughly $100 million of stranded costs with a remediation plan. Management authorized a $2.5 billion share-repurchase program and reiterated 2026 continuing-operations guidance of $7.4–7.6 billion in sales and $1.53–1.6 billion in EBITDA, expecting improved free cash flow despite near-term transaction-related working-capital headwinds. » More on finance.yahoo.com
IFF sells division for botanical extracts to SuanNutra
IFF sells its portfolio for botanical extracts, vitamins, minerals as well as parts of food enhancement and the range of natural colorants and antioxidants to SuanNutra. The divested units generated around $170 million in revenue in 2025, involve about 600 employees and five production sites in Europe, the US and Latin America. The sale represents less than 2% of group revenue; closing is expected by the end of 2026 and is subject to customary approval and consultation conditions. » More on de.investing.com
International Flavors & Fragrances seen as deep-value pick by Heartland on discounted valuation
Heartland Mid Cap Value Fund designated International Flavors & Fragrances as a new deep-value holding, citing management's multi-year portfolio streamlining toward higher-margin businesses and improved capital allocation. The fund highlights balanced revenue across Taste, Health & Biosciences and Scent, expanding leadership in fabric care and other scent applications. Heartland points to rising growth, margins and free cash flow and notes IFF trades at about 12.23x forward EBITDA versus Givaudan at 19.14x, while management has initiated the first share buyback in six years. » More on finance.yahoo.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 1.71bn | 25.32% |
| Gross profit | 728.35m | 13.05% |
| Net profit | -48.56m | 242.46% |
| EBITDA | 54.74m | 81.70% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €20.06bn |
Number of shares | 255.15m |
52-week high/low | €85.44 - €55.36 |
Dividend yield | 1.87% |
Dividends TTM | €1.39 |
Beta | 0.88 |
P/E ratio | 115.36 |
PEG ratio | 5.02 |
P/B ratio | 1.67 |
P/S ratio | 2.42 |
Company profile
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
| Name | Intl Flavors & Fragrances |
| CEO | Jon Erik Fyrwald |
| Headquarters | New York City,
ny USA |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 17/12/1974 |
| Employees | 21,500 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | IFF |
Frankfurt | IFF.F |
Düsseldorf | IFF.DU |
London | 0RF3.L |
SIX | IFF.SW |
München | IFF.MU |
Wien | IFF.VI |